IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 13 filers reported holding IMMUNE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $26,000 | – | 138,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 251,029 | $47,000 | 0.06% |
| Intellectus Partners, LLC | 31,082 | $6,000 | 0.00% |
| VANGUARD GROUP INC | 136,841 | $26,000 | 0.00% |
| UBS Group AG | 5 | $0 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 88,575 | $16,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 22,355 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 4 | $0 | 0.00% |
| CREDIT SUISSE AG/ | 38,399 | $7,000 | 0.00% |
| MORGAN STANLEY | 3 | $0 | 0.00% |
| BlackRock Inc. | 568 | $0 | 0.00% |